ReviewVirchows Archiv : an international journal of pathology2006
Current practice of Gleason grading of prostate carcinoma.
Review in Virchows Archiv : an international journal of pathology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- CD63 is a diagnostic marker of prostate cancer and a prognostic marker of biochemical progression following radical prostatectomy.Histology and histopathology · 2026Article
- Synchronous bladder and prostate cancer specimens obtained from radical cystoprostatectomy: A single‑center retrospective analysis.Experimental and therapeutic medicine · 2023Article
- Concomitant bladder cancer and prostate cancer: challenges and controversies.Nature reviews. Urology · 2017Review
- The evolving Gleason grading system.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2016Review
- [Documentation quality of histopathology reports of prostate needle biopsies: a snapshot].Der Urologe. Ausg. A · 2014Article
- Synchronous bladder and prostate cancers in the specimens of radical cystoprostatectomy: a multicenter retrospective analysis.The Kaohsiung journal of medical sciences · 2014Article
- Mechanisms of Androgen-Independent Prostate Cancer.EJIFCC · 2014Article
- PTPL1 and PKCδ contribute to proapoptotic signalling in prostate cancer cells.Cell death & disease · 2013Article
- [Importance of second opinions on histology of prostate biopsy specimens].Der Pathologe · 2012Article
- Biomarker research in prostate cancer--towards utility, not futility.Nature reviews. Urology · 2011Review
- [Diagnostic of prostate cancer: conventional and molecular or cell biological methods].Der Pathologe · 2009Review
- TRPV6 alleles do not influence prostate cancer progression.BMC cancer · 2009Article
- Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis.Pathology oncology research : POR · 2009Article
- Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays.PloS one · 2009Article
- Reproducibility and reliability of tumor grading in urological neoplasms.World journal of urology · 2007Review
- [The value of the modified Gleason grading system of prostate adenocarcinoma in routine urological diagnostics].Der Urologe. Ausg. A · 2007Review
- Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer.Journal of molecular medicine (Berlin, Germany) · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Gleason grading system remains one of the most powerful prognostic factors in prostate cancer and is the dominant method around the world in daily practice. It is based solely on the glandular architecture performed at low magnification. The Gleason grading system should be performed in needle core biopsies and radical prostatectomy specimens where it shows a reasonable degree of correlation between both specimens, and most importantly, it remains vital in the treatment decision-making process. This review summarizes the current status of Gleason grading in prostate cancer, incorporating recent proposals for the best contemporary practice of prostate cancer grading.
Indexed as
Identifiers
16328356What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.